Remdesivir (deuterated) hydrobromide oral suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Remdesivir (deuterated) hydrobromide oral suspension, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults [Phase 1]